Smart probe could help surgeons remove all cancer in one go
NCT ID NCT05104619
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called SpiderMass that analyzes tissue molecules in real time during tongue cancer surgery. The goal is to help surgeons instantly tell cancerous from healthy tissue, so they can remove all the tumor in one operation. Currently, about 15-30% of patients need additional treatment because cancer cells are found at the surgical edge days later. This trial enrolls 33 adults with squamous cell carcinoma of the tongue who are having surgery as their first treatment. The device is being trained to recognize cancer patterns, which is the first step toward using it as a surgical guide.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SpiderMass spectroscopy probe
What this could lead to
If successful, this technology could help surgeons remove all cancer during one operation, reducing the need for follow-up treatments.
What could go wrong
This is an early learning phase with only 33 participants. The technology must first be trained to distinguish healthy from cancerous tissue, and it may not work in all cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire d'Amiens
RECRUITINGAmiens, Picardie, 80000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••